...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: FDA

If the sub-group with Rosuvastatin has outstanding results, the FDA may approve a NDA. They have approved some that have missed the primary endpoint. Or maybe in Europe (EMA)? How about China? 

  

8
Sep 30, 2019 02:11PM
1
Sep 30, 2019 02:19PM
1
Sep 30, 2019 03:03PM
1
Oct 01, 2019 12:28AM
8
Oct 01, 2019 12:55AM
Share
New Message
Please login to post a reply